DIGITAL DROPLET PCR IS A PROMISING TOOL FOR DETECTING ABL1 T315I MUTATION IN CHRONIC MYELOID LEUKEMIA PATIENTS: THE EXPERIENCE OF ITALIAN "CML CAMPUS"

被引：0
|
作者：
Galimberti, S. [1 ]
Guerrini, F. [1 ]
Grassi, S. [1 ]
Bocchia, M. [2 ]
Bavaro, L. [3 ]
Dragani, M. [4 ]
Gottardi, E. M. [5 ]
Izzo, B. [6 ]
Lunghi, F.
Quarantelli, F. [6 ]
Serra, A. [5 ]
Sicuranza, A. [2 ]
Cambrin, G. Rege [4 ]
Soverini, S. [3 ]
机构：
[1] Univ Pisa, Dept Clin & Expt Med, UO Hematol, Pisa, Italy
[2] Azienda Osped Univ Senese, Hematol Unit, Dept Med Surg & Neurosci, Siena, Italy
[3] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[4] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
[5] Univ Federico II, Dept Clin Med & Surg, Mol Biol, Naples, Italy
[6] IRCCS San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C056
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [11] The Clinical Characteristics and Efficacy of Chronic Myeloid Leukemia Patients with T315I Mutation
    Chen Chen
    Na Xu
    Wu WanEr
    Liu Liang
    Xuan Zhou
    Huang JiXian
    Yin Changxin
    Rui Cao
    Liu, Qifa
    Liu Xiaoli
    BLOOD, 2018, 132
  • [12] Characteristics and outcome of patients with chronic myeloid leukemia (CML) and T315I mutation following failure of imatinib mesylate therapy
    Jabbour, Elias
    Kantarjiah, Hagop
    Jones, Dan
    Verstovsek, Srdan
    Ferrajoli, Alessandra
    Ravandi, Farhad
    O'Brien, Susan
    Cortes, Jorge
    BLOOD, 2007, 110 (11) : 577A - 578A
  • [13] Quantitative detection of T315I mutations of BCR::ABL1 using digital droplet polymerase chain reaction
    Mu, Huijun
    Zou, Jian
    Zhang, Haiping
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S79 - S85
  • [14] Treatment of an Adolescent With Chronic Myeloid Leukemia and the T315I Mutation With Ponatinib
    Nickel, Robert Sheppard
    Daves, Marla
    Keller, Frank
    PEDIATRIC BLOOD & CANCER, 2015, 62 (11) : 2050 - 2051
  • [15] Lack of BCR-ABL T315I Mutation in Tunisian Patients with Imatinib-Resistant Chronic Myeloid Leukemia
    El Aoud, Amina
    Kamoun, Hassen
    Frikha, Rim
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 267 - 268
  • [16] Quantitative detection of T315I mutations of BCR::ABL1 using digital droplet polymerase chain reaction
    Mu, Huijun
    Zou, Jian
    Zhang, Haiping
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S79 - S85
  • [17] METABOLIC CHARACTERISTICS OF IMATINIB RESISTANT CHRONIC MYELOID LEUKEMIA WITH T315I MUTATION
    Heo, J. Y.
    Han, J.
    Ryu, M. J.
    Jang, Y.
    Kim, S. J.
    Kim, J.
    Lee, M. J.
    Kweon, G. R.
    HAEMATOLOGICA, 2015, 100 : 432 - 432
  • [18] Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance
    Chahardouli, Bahram
    Zaker, Farhad
    Mousavi, Seied Asadollah
    Kazemi, Ahmad
    Ostadali, Mohammadreza
    Nadali, Fatemeh
    Rostami, Shahrbano
    Alimoghaddam, Kamran
    Ghavamzade, Ardeshir
    HEMATOLOGY, 2013, 18 (03) : 158 - 162
  • [19] Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor, in Patients with Chronic Myeloid Leukemia Carrying the T315I Mutation in a Phase 1 Trial
    Rea, Delphine
    Lang, Fabian
    Kim, Dong-Wook
    Cortes, Jorge E.
    Hughes, Timothy P.
    Minami, Hironobu
    Breccia, Massimo
    Deangelo, Daniel J.
    Hochhaus, Andreas
    Talpaz, Moshe
    Goh, Yeow Tee
    le Coutre, Philipp
    Deininger, Michael W.
    Etienne, Gabriel
    Sondhi, Manu
    Mishra, Kaushal
    Aimone, Paola
    Ng-Sikorski, Janet
    Mauro, Michael J.
    BLOOD, 2018, 132
  • [20] High sensitivity assay for detection BCR-ABL with T315I mutation in CML patients
    Chen, R. S.
    Bagaskoro, F.
    Handayani, D. A.
    CLINICA CHIMICA ACTA, 2019, 493 : S580 - S580
12345